See Clearly Vision is owned and directed by Rajesh K. Rajpal, M.D. He is a leader in the cataract, corneal, and refractive surgery communities, speaking to his colleagues at conventions and meetings all over the world. He is also a participating physician in many FDA studies. Before a drug can be marketed and sold in the U.S., the FDA must assess its safety and effectiveness for those that will be using the drug.
See Clearly Vision was chosen to be an FDA Study Site to determine whether Lotemax Gel 0.5% would be safe to use with patients recovering from cataract removal surgery. As with any surgery, there will be inflammation throughout the surgical eye and some general ocular discomfort. These symptoms are remedied by the use of steroid drops. In the past, surgeons have used several types of steroid drops to increase patient comfort and decrease the inflammation; they have proven very effective. However, some of those drops had side effects that were not pleasing to the surgeon. Bausch & Lomb derived a new formulation and Dr. Rajpal was selected to be the lead investigator in the FDA study. Ultimately, the drug was FDA approved as being safe and effective in post-operative cataract patients.
To read Dr. Rajpal’s article recently published in the Journal of Cataract and Refractive Surgery, click on the following link: (Link No Longer Active)